- Home
- HMC vs EW Comparison
HMC vs EW Comparison
Compare HMC & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMC
- EW
- Stock Information
- Founded
- HMC 1946
- EW 1958
- Country
- HMC Japan
- EW United States
- Employees
- HMC N/A
- EW N/A
- Industry
- HMC Auto Manufacturing
- EW Industrial Specialties
- Sector
- HMC Consumer Discretionary
- EW Health Care
- Exchange
- HMC Nasdaq
- EW Nasdaq
- Market Cap
- HMC 41.4B
- EW 44.8B
- IPO Year
- HMC 1957
- EW 2000
- Fundamental
- Price
- HMC $29.26
- EW $77.20
- Analyst Decision
- HMC Hold
- EW Buy
- Analyst Count
- HMC 1
- EW 20
- Target Price
- HMC N/A
- EW $80.20
- AVG Volume (30 Days)
- HMC 826.3K
- EW 3.6M
- Earning Date
- HMC 08-06-2025
- EW 07-23-2025
- Dividend Yield
- HMC 3.64%
- EW N/A
- EPS Growth
- HMC N/A
- EW 200.69
- EPS
- HMC 1.19
- EW 7.02
- Revenue
- HMC $144,835,113,507.00
- EW $5,522,300,000.00
- Revenue This Year
- HMC $1.26
- EW $11.81
- Revenue Next Year
- HMC $2.92
- EW $9.54
- P/E Ratio
- HMC $7.23
- EW $32.32
- Revenue Growth
- HMC 6.17
- EW 8.23
- 52 Week Low
- HMC $23.41
- EW $58.93
- 52 Week High
- HMC $33.72
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- HMC 48.67
- EW 55.96
- Support Level
- HMC $28.82
- EW $72.42
- Resistance Level
- HMC $29.87
- EW $78.53
- Average True Range (ATR)
- HMC 0.25
- EW 1.46
- MACD
- HMC -0.01
- EW 0.24
- Stochastic Oscillator
- HMC 45.43
- EW 78.23
About HMC Honda Motor Company Ltd.
Incorporated in 1948, Honda Motor was originally a motorcycle manufacturer. Today, the firm makes automobiles, motorcycles, and power products such as boat engines, generators, and lawnmowers. Including joint ventures, Honda sold 3.7 million light vehicles and 20.6 million motorcycles in fiscal 2025, and consolidated sales were JPY 21.7 trillion. Automobiles constitute 65% of revenue and motorcycles 17%, with the rest split between power products and financial services. Honda also makes robots and private jets.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.